<DOC>
	<DOC>NCT02353650</DOC>
	<brief_summary>The study is a randomised double-blinded trial. A group of 40 tinnitus patients with a naturally low Q10 level will be selected out of a preselected group of 160 screened out of a pre-existed database or patients which visited the ENT-consultation. The 40 patients with the lowest level will be asked to take 2 months Q10 (n=20) or the placebo (n=20). To evaluate the effect on hearing and tinnitus characteristic; audiometric test, tinnitus analysis and auditory evoked responses will be used as outcome measurements.</brief_summary>
	<brief_title>The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>chronic nonpulsatile tinnitus &gt; 3 months tinnitus has a clear otological cause age &gt; 18 years pulsatile tinnitus persons who take already Q10 pregnancy cervical tinnitus holocranial tinnitus depression mental of neurological disorders history of chemotherapy middle ear diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Q10</keyword>
	<keyword>ubiquinol</keyword>
</DOC>